Global Jet Lag Therapy

Jet Lag Therapy Comprehensive Study by Application (Business Travelers, Cabin Crew, Athletes, Seasonal Travelers, Others), End Users (Hospital Pharmacies, Retail Pharmacies, Online Sales, Drug Stores), Route Of Administration (Oral, Injection), Drug Class (Non-Benzodiazepines, Benzodiazepines, Over The Counter Drugs, Melatonin, Herbal and Natural Products), Devices (Prescription Medication, Jet Lag Wearable Devices, LightBox, Melatonin, Herbal Medication) Players and Region - Global Market Outlook to 2030

Jet Lag Therapy Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Jet Lag Therapy
Jet Lag therapy is a treatment which required to overcome jet lag after traveling. Jet lag is also known as zone change syndrome which happens because of rapid traveling across various time zones. Basically, it cures physiological conditions that can result as disruption in the body’s circadian rhythms. This market is having strong potential in future because of increasing number of travellers across the globes. With the increasing concern towards chronic diseases, along with the rising number of an increasing number of cases related to insomnia, sleepiness, and daytime fatigue.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The global jet lag therapy market is highly competitive. Leading players are performing in this market focus more on R&D activities to develop the new product portfolio. The major applications are developed by players to enhance their presence. The companies are enhancing the market by various market strategies such as mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. Analyst at AMA Research estimates that Canada Players will contribute the maximum growth to Global Jet Lag Therapy market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Ayo (Novalogy) (United States), The Litebook Company Ltd (Canada), Lucimed (Belgium), Clinigen Group (United Kingdom), Vanda Pharmaceuticals (United States), Pfizer (United States), Jamieson Laboratories Ltd. (Canada), Lumie (United Kingdom), Northern Light Technologies (Canada) and Propeaq (Netherlands) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Re-Timer (Australia), HumanCharger (Finland) and Verilux, Inc. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Jet Lag Therapy market by , Application (Business Travelers, Cabin Crew, Athletes, Seasonal Travelers and Others) and Region.



On the basis of geography, the market of Jet Lag Therapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Users, the sub-segment i.e. Hospital Pharmacies will boost the Jet Lag Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Route Of Administration, the sub-segment i.e. Oral will boost the Jet Lag Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Drug Class, the sub-segment i.e. Non-Benzodiazepines will boost the Jet Lag Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Devices, the sub-segment i.e. Prescription Medication will boost the Jet Lag Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technology Advancement in Components in Therapies and Increasing Number of Launches of Insomnia Related Products

Market Growth Drivers:
Rise in the number of travelers, from the last few years, the number of international travelers passing through US airports has increased as 124.2 million in 2017. This will create a huge growth opportunity in the future. Another reason behind it is increasing the purchasing power of the consumers.

Challenges:
Rising Concern towards Side Effects

Restraints:
Lack of Consumer Awareness and Rising Presence of Substitute Therapies Which Can Be Restraining the Market Growth

Opportunities:
Increasing Number of Wearable Devices

In August 2019, Virgin Atlantic to offer sleep meditation on flights for passengers and crew members to manage jet lag. Sleep by Headspace launched worldwide in September 2018 and is specifically tailored to create the ideal conditions for a healthy, restful sleep. The Headspace Sleep team developed the new collection based on prototypes tested with real users, as well as a review of existing clinical research.


Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Jet Lag Therapy Service Provider, Government Regulatory and Research Organizations and End-Use Industries

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Business Travelers
  • Cabin Crew
  • Athletes
  • Seasonal Travelers
  • Others
By End Users
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales
  • Drug Stores

By Route Of Administration
  • Oral
  • Injection

By Drug Class
  • Non-Benzodiazepines
  • Benzodiazepines
  • Over The Counter Drugs
  • Melatonin
  • Herbal and Natural Products

By Devices
  • Prescription Medication
  • Jet Lag Wearable Devices
  • LightBox
  • Melatonin
  • Herbal Medication

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in the number of travelers, from the last few years, the number of international travelers passing through US airports has increased as 124.2 million in 2017. This will create a huge growth opportunity in the future. Another reason behind it is increasing the purchasing power of the consumers.
    • 3.3. Market Challenges
      • 3.3.1. Rising Concern towards Side Effects
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement in Components in Therapies
      • 3.4.2. Increasing Number of Launches of Insomnia Related Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Jet Lag Therapy, by Application, End Users, Route Of Administration, Drug Class, Devices and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Jet Lag Therapy (Value)
      • 5.2.1. Global Jet Lag Therapy by: Application (Value)
        • 5.2.1.1. Business Travelers
        • 5.2.1.2. Cabin Crew
        • 5.2.1.3. Athletes
        • 5.2.1.4. Seasonal Travelers
        • 5.2.1.5. Others
      • 5.2.2. Global Jet Lag Therapy by: End Users (Value)
        • 5.2.2.1. Hospital Pharmacies
        • 5.2.2.2. Retail Pharmacies
        • 5.2.2.3. Online Sales
        • 5.2.2.4. Drug Stores
      • 5.2.3. Global Jet Lag Therapy by: Route Of Administration (Value)
        • 5.2.3.1. Oral
        • 5.2.3.2. Injection
      • 5.2.4. Global Jet Lag Therapy by: Drug Class (Value)
        • 5.2.4.1. Non-Benzodiazepines
        • 5.2.4.2. Benzodiazepines
        • 5.2.4.3. Over The Counter Drugs
        • 5.2.4.4. Melatonin
        • 5.2.4.5. Herbal and Natural Products
      • 5.2.5. Global Jet Lag Therapy by: Devices (Value)
        • 5.2.5.1. Prescription Medication
        • 5.2.5.2. Jet Lag Wearable Devices
        • 5.2.5.3. LightBox
        • 5.2.5.4. Melatonin
        • 5.2.5.5. Herbal Medication
      • 5.2.6. Global Jet Lag Therapy Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Jet Lag Therapy (Volume)
      • 5.3.1. Global Jet Lag Therapy by: Application (Volume)
        • 5.3.1.1. Business Travelers
        • 5.3.1.2. Cabin Crew
        • 5.3.1.3. Athletes
        • 5.3.1.4. Seasonal Travelers
        • 5.3.1.5. Others
      • 5.3.2. Global Jet Lag Therapy by: End Users (Volume)
        • 5.3.2.1. Hospital Pharmacies
        • 5.3.2.2. Retail Pharmacies
        • 5.3.2.3. Online Sales
        • 5.3.2.4. Drug Stores
      • 5.3.3. Global Jet Lag Therapy by: Route Of Administration (Volume)
        • 5.3.3.1. Oral
        • 5.3.3.2. Injection
      • 5.3.4. Global Jet Lag Therapy by: Drug Class (Volume)
        • 5.3.4.1. Non-Benzodiazepines
        • 5.3.4.2. Benzodiazepines
        • 5.3.4.3. Over The Counter Drugs
        • 5.3.4.4. Melatonin
        • 5.3.4.5. Herbal and Natural Products
      • 5.3.5. Global Jet Lag Therapy by: Devices (Volume)
        • 5.3.5.1. Prescription Medication
        • 5.3.5.2. Jet Lag Wearable Devices
        • 5.3.5.3. LightBox
        • 5.3.5.4. Melatonin
        • 5.3.5.5. Herbal Medication
      • 5.3.6. Global Jet Lag Therapy Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Jet Lag Therapy (Price)
  • 6. Jet Lag Therapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Ayo (Novalogy) (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. The Litebook Company Ltd (Canada)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Lucimed (Belgium)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Clinigen Group (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Vanda Pharmaceuticals (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Pfizer (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Jamieson Laboratories Ltd. (Canada)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Lumie (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Northern Light Technologies (Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Propeaq (Netherlands)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Jet Lag Therapy Sale, by Application, End Users, Route Of Administration, Drug Class, Devices and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Jet Lag Therapy (Value)
      • 7.2.1. Global Jet Lag Therapy by: Application (Value)
        • 7.2.1.1. Business Travelers
        • 7.2.1.2. Cabin Crew
        • 7.2.1.3. Athletes
        • 7.2.1.4. Seasonal Travelers
        • 7.2.1.5. Others
      • 7.2.2. Global Jet Lag Therapy by: End Users (Value)
        • 7.2.2.1. Hospital Pharmacies
        • 7.2.2.2. Retail Pharmacies
        • 7.2.2.3. Online Sales
        • 7.2.2.4. Drug Stores
      • 7.2.3. Global Jet Lag Therapy by: Route Of Administration (Value)
        • 7.2.3.1. Oral
        • 7.2.3.2. Injection
      • 7.2.4. Global Jet Lag Therapy by: Drug Class (Value)
        • 7.2.4.1. Non-Benzodiazepines
        • 7.2.4.2. Benzodiazepines
        • 7.2.4.3. Over The Counter Drugs
        • 7.2.4.4. Melatonin
        • 7.2.4.5. Herbal and Natural Products
      • 7.2.5. Global Jet Lag Therapy by: Devices (Value)
        • 7.2.5.1. Prescription Medication
        • 7.2.5.2. Jet Lag Wearable Devices
        • 7.2.5.3. LightBox
        • 7.2.5.4. Melatonin
        • 7.2.5.5. Herbal Medication
      • 7.2.6. Global Jet Lag Therapy Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Jet Lag Therapy (Volume)
      • 7.3.1. Global Jet Lag Therapy by: Application (Volume)
        • 7.3.1.1. Business Travelers
        • 7.3.1.2. Cabin Crew
        • 7.3.1.3. Athletes
        • 7.3.1.4. Seasonal Travelers
        • 7.3.1.5. Others
      • 7.3.2. Global Jet Lag Therapy by: End Users (Volume)
        • 7.3.2.1. Hospital Pharmacies
        • 7.3.2.2. Retail Pharmacies
        • 7.3.2.3. Online Sales
        • 7.3.2.4. Drug Stores
      • 7.3.3. Global Jet Lag Therapy by: Route Of Administration (Volume)
        • 7.3.3.1. Oral
        • 7.3.3.2. Injection
      • 7.3.4. Global Jet Lag Therapy by: Drug Class (Volume)
        • 7.3.4.1. Non-Benzodiazepines
        • 7.3.4.2. Benzodiazepines
        • 7.3.4.3. Over The Counter Drugs
        • 7.3.4.4. Melatonin
        • 7.3.4.5. Herbal and Natural Products
      • 7.3.5. Global Jet Lag Therapy by: Devices (Volume)
        • 7.3.5.1. Prescription Medication
        • 7.3.5.2. Jet Lag Wearable Devices
        • 7.3.5.3. LightBox
        • 7.3.5.4. Melatonin
        • 7.3.5.5. Herbal Medication
      • 7.3.6. Global Jet Lag Therapy Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Jet Lag Therapy (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Jet Lag Therapy: by Application(USD Million)
  • Table 2. Jet Lag Therapy Business Travelers , by Region USD Million (2018-2023)
  • Table 3. Jet Lag Therapy Cabin Crew , by Region USD Million (2018-2023)
  • Table 4. Jet Lag Therapy Athletes , by Region USD Million (2018-2023)
  • Table 5. Jet Lag Therapy Seasonal Travelers , by Region USD Million (2018-2023)
  • Table 6. Jet Lag Therapy Others , by Region USD Million (2018-2023)
  • Table 7. Jet Lag Therapy: by End Users(USD Million)
  • Table 8. Jet Lag Therapy Hospital Pharmacies , by Region USD Million (2018-2023)
  • Table 9. Jet Lag Therapy Retail Pharmacies , by Region USD Million (2018-2023)
  • Table 10. Jet Lag Therapy Online Sales , by Region USD Million (2018-2023)
  • Table 11. Jet Lag Therapy Drug Stores , by Region USD Million (2018-2023)
  • Table 12. Jet Lag Therapy: by Route Of Administration(USD Million)
  • Table 13. Jet Lag Therapy Oral , by Region USD Million (2018-2023)
  • Table 14. Jet Lag Therapy Injection , by Region USD Million (2018-2023)
  • Table 15. Jet Lag Therapy: by Drug Class(USD Million)
  • Table 16. Jet Lag Therapy Non-Benzodiazepines , by Region USD Million (2018-2023)
  • Table 17. Jet Lag Therapy Benzodiazepines , by Region USD Million (2018-2023)
  • Table 18. Jet Lag Therapy Over The Counter Drugs , by Region USD Million (2018-2023)
  • Table 19. Jet Lag Therapy Melatonin , by Region USD Million (2018-2023)
  • Table 20. Jet Lag Therapy Herbal and Natural Products , by Region USD Million (2018-2023)
  • Table 21. Jet Lag Therapy: by Devices(USD Million)
  • Table 22. Jet Lag Therapy Prescription Medication , by Region USD Million (2018-2023)
  • Table 23. Jet Lag Therapy Jet Lag Wearable Devices , by Region USD Million (2018-2023)
  • Table 24. Jet Lag Therapy LightBox , by Region USD Million (2018-2023)
  • Table 25. Jet Lag Therapy Melatonin , by Region USD Million (2018-2023)
  • Table 26. Jet Lag Therapy Herbal Medication , by Region USD Million (2018-2023)
  • Table 27. South America Jet Lag Therapy, by Country USD Million (2018-2023)
  • Table 28. South America Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 29. South America Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 30. South America Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 31. South America Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 32. South America Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 33. Brazil Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 34. Brazil Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 35. Brazil Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 36. Brazil Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 37. Brazil Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 38. Argentina Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 39. Argentina Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 40. Argentina Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 41. Argentina Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 42. Argentina Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 43. Rest of South America Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 44. Rest of South America Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 45. Rest of South America Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 46. Rest of South America Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 47. Rest of South America Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 48. Asia Pacific Jet Lag Therapy, by Country USD Million (2018-2023)
  • Table 49. Asia Pacific Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 50. Asia Pacific Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 51. Asia Pacific Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 52. Asia Pacific Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 53. Asia Pacific Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 54. China Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 55. China Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 56. China Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 57. China Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 58. China Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 59. Japan Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 60. Japan Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 61. Japan Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 62. Japan Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 63. Japan Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 64. India Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 65. India Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 66. India Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 67. India Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 68. India Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 69. South Korea Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 70. South Korea Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 71. South Korea Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 72. South Korea Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 73. South Korea Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 74. Taiwan Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 75. Taiwan Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 76. Taiwan Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 77. Taiwan Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 78. Taiwan Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 79. Australia Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 80. Australia Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 81. Australia Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 82. Australia Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 83. Australia Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 84. Rest of Asia-Pacific Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 85. Rest of Asia-Pacific Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 86. Rest of Asia-Pacific Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 87. Rest of Asia-Pacific Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 88. Rest of Asia-Pacific Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 89. Europe Jet Lag Therapy, by Country USD Million (2018-2023)
  • Table 90. Europe Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 91. Europe Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 92. Europe Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 93. Europe Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 94. Europe Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 95. Germany Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 96. Germany Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 97. Germany Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 98. Germany Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 99. Germany Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 100. France Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 101. France Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 102. France Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 103. France Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 104. France Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 105. Italy Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 106. Italy Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 107. Italy Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 108. Italy Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 109. Italy Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 110. United Kingdom Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 111. United Kingdom Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 112. United Kingdom Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 113. United Kingdom Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 114. United Kingdom Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 115. Netherlands Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 116. Netherlands Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 117. Netherlands Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 118. Netherlands Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 119. Netherlands Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 120. Rest of Europe Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 121. Rest of Europe Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 122. Rest of Europe Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 123. Rest of Europe Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 124. Rest of Europe Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 125. MEA Jet Lag Therapy, by Country USD Million (2018-2023)
  • Table 126. MEA Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 127. MEA Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 128. MEA Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 129. MEA Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 130. MEA Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 131. Middle East Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 132. Middle East Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 133. Middle East Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 134. Middle East Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 135. Middle East Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 136. Africa Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 137. Africa Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 138. Africa Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 139. Africa Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 140. Africa Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 141. North America Jet Lag Therapy, by Country USD Million (2018-2023)
  • Table 142. North America Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 143. North America Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 144. North America Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 145. North America Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 146. North America Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 147. United States Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 148. United States Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 149. United States Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 150. United States Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 151. United States Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 152. Canada Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 153. Canada Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 154. Canada Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 155. Canada Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 156. Canada Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 157. Mexico Jet Lag Therapy, by Application USD Million (2018-2023)
  • Table 158. Mexico Jet Lag Therapy, by End Users USD Million (2018-2023)
  • Table 159. Mexico Jet Lag Therapy, by Route Of Administration USD Million (2018-2023)
  • Table 160. Mexico Jet Lag Therapy, by Drug Class USD Million (2018-2023)
  • Table 161. Mexico Jet Lag Therapy, by Devices USD Million (2018-2023)
  • Table 162. Jet Lag Therapy Sales: by Application(K Units)
  • Table 163. Jet Lag Therapy Sales Business Travelers , by Region K Units (2018-2023)
  • Table 164. Jet Lag Therapy Sales Cabin Crew , by Region K Units (2018-2023)
  • Table 165. Jet Lag Therapy Sales Athletes , by Region K Units (2018-2023)
  • Table 166. Jet Lag Therapy Sales Seasonal Travelers , by Region K Units (2018-2023)
  • Table 167. Jet Lag Therapy Sales Others , by Region K Units (2018-2023)
  • Table 168. Jet Lag Therapy Sales: by End Users(K Units)
  • Table 169. Jet Lag Therapy Sales Hospital Pharmacies , by Region K Units (2018-2023)
  • Table 170. Jet Lag Therapy Sales Retail Pharmacies , by Region K Units (2018-2023)
  • Table 171. Jet Lag Therapy Sales Online Sales , by Region K Units (2018-2023)
  • Table 172. Jet Lag Therapy Sales Drug Stores , by Region K Units (2018-2023)
  • Table 173. Jet Lag Therapy Sales: by Route Of Administration(K Units)
  • Table 174. Jet Lag Therapy Sales Oral , by Region K Units (2018-2023)
  • Table 175. Jet Lag Therapy Sales Injection , by Region K Units (2018-2023)
  • Table 176. Jet Lag Therapy Sales: by Drug Class(K Units)
  • Table 177. Jet Lag Therapy Sales Non-Benzodiazepines , by Region K Units (2018-2023)
  • Table 178. Jet Lag Therapy Sales Benzodiazepines , by Region K Units (2018-2023)
  • Table 179. Jet Lag Therapy Sales Over The Counter Drugs , by Region K Units (2018-2023)
  • Table 180. Jet Lag Therapy Sales Melatonin , by Region K Units (2018-2023)
  • Table 181. Jet Lag Therapy Sales Herbal and Natural Products , by Region K Units (2018-2023)
  • Table 182. Jet Lag Therapy Sales: by Devices(K Units)
  • Table 183. Jet Lag Therapy Sales Prescription Medication , by Region K Units (2018-2023)
  • Table 184. Jet Lag Therapy Sales Jet Lag Wearable Devices , by Region K Units (2018-2023)
  • Table 185. Jet Lag Therapy Sales LightBox , by Region K Units (2018-2023)
  • Table 186. Jet Lag Therapy Sales Melatonin , by Region K Units (2018-2023)
  • Table 187. Jet Lag Therapy Sales Herbal Medication , by Region K Units (2018-2023)
  • Table 188. South America Jet Lag Therapy Sales, by Country K Units (2018-2023)
  • Table 189. South America Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 190. South America Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 191. South America Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 192. South America Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 193. South America Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 194. Brazil Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 195. Brazil Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 196. Brazil Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 197. Brazil Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 198. Brazil Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 199. Argentina Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 200. Argentina Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 201. Argentina Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 202. Argentina Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 203. Argentina Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 204. Rest of South America Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 205. Rest of South America Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 206. Rest of South America Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 207. Rest of South America Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 208. Rest of South America Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 209. Asia Pacific Jet Lag Therapy Sales, by Country K Units (2018-2023)
  • Table 210. Asia Pacific Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 211. Asia Pacific Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 212. Asia Pacific Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 213. Asia Pacific Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 214. Asia Pacific Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 215. China Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 216. China Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 217. China Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 218. China Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 219. China Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 220. Japan Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 221. Japan Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 222. Japan Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 223. Japan Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 224. Japan Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 225. India Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 226. India Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 227. India Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 228. India Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 229. India Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 230. South Korea Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 231. South Korea Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 232. South Korea Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 233. South Korea Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 234. South Korea Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 235. Taiwan Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 236. Taiwan Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 237. Taiwan Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 238. Taiwan Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 239. Taiwan Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 240. Australia Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 241. Australia Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 242. Australia Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 243. Australia Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 244. Australia Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 245. Rest of Asia-Pacific Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 246. Rest of Asia-Pacific Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 247. Rest of Asia-Pacific Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 248. Rest of Asia-Pacific Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 249. Rest of Asia-Pacific Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 250. Europe Jet Lag Therapy Sales, by Country K Units (2018-2023)
  • Table 251. Europe Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 252. Europe Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 253. Europe Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 254. Europe Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 255. Europe Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 256. Germany Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 257. Germany Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 258. Germany Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 259. Germany Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 260. Germany Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 261. France Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 262. France Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 263. France Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 264. France Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 265. France Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 266. Italy Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 267. Italy Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 268. Italy Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 269. Italy Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 270. Italy Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 271. United Kingdom Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 272. United Kingdom Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 273. United Kingdom Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 274. United Kingdom Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 275. United Kingdom Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 276. Netherlands Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 277. Netherlands Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 278. Netherlands Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 279. Netherlands Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 280. Netherlands Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 281. Rest of Europe Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 282. Rest of Europe Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 283. Rest of Europe Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 284. Rest of Europe Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 285. Rest of Europe Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 286. MEA Jet Lag Therapy Sales, by Country K Units (2018-2023)
  • Table 287. MEA Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 288. MEA Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 289. MEA Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 290. MEA Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 291. MEA Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 292. Middle East Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 293. Middle East Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 294. Middle East Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 295. Middle East Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 296. Middle East Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 297. Africa Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 298. Africa Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 299. Africa Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 300. Africa Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 301. Africa Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 302. North America Jet Lag Therapy Sales, by Country K Units (2018-2023)
  • Table 303. North America Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 304. North America Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 305. North America Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 306. North America Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 307. North America Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 308. United States Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 309. United States Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 310. United States Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 311. United States Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 312. United States Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 313. Canada Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 314. Canada Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 315. Canada Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 316. Canada Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 317. Canada Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 318. Mexico Jet Lag Therapy Sales, by Application K Units (2018-2023)
  • Table 319. Mexico Jet Lag Therapy Sales, by End Users K Units (2018-2023)
  • Table 320. Mexico Jet Lag Therapy Sales, by Route Of Administration K Units (2018-2023)
  • Table 321. Mexico Jet Lag Therapy Sales, by Drug Class K Units (2018-2023)
  • Table 322. Mexico Jet Lag Therapy Sales, by Devices K Units (2018-2023)
  • Table 323. Company Basic Information, Sales Area and Its Competitors
  • Table 324. Company Basic Information, Sales Area and Its Competitors
  • Table 325. Company Basic Information, Sales Area and Its Competitors
  • Table 326. Company Basic Information, Sales Area and Its Competitors
  • Table 327. Company Basic Information, Sales Area and Its Competitors
  • Table 328. Company Basic Information, Sales Area and Its Competitors
  • Table 329. Company Basic Information, Sales Area and Its Competitors
  • Table 330. Company Basic Information, Sales Area and Its Competitors
  • Table 331. Company Basic Information, Sales Area and Its Competitors
  • Table 332. Company Basic Information, Sales Area and Its Competitors
  • Table 333. Jet Lag Therapy: by Application(USD Million)
  • Table 334. Jet Lag Therapy Business Travelers , by Region USD Million (2025-2030)
  • Table 335. Jet Lag Therapy Cabin Crew , by Region USD Million (2025-2030)
  • Table 336. Jet Lag Therapy Athletes , by Region USD Million (2025-2030)
  • Table 337. Jet Lag Therapy Seasonal Travelers , by Region USD Million (2025-2030)
  • Table 338. Jet Lag Therapy Others , by Region USD Million (2025-2030)
  • Table 339. Jet Lag Therapy: by End Users(USD Million)
  • Table 340. Jet Lag Therapy Hospital Pharmacies , by Region USD Million (2025-2030)
  • Table 341. Jet Lag Therapy Retail Pharmacies , by Region USD Million (2025-2030)
  • Table 342. Jet Lag Therapy Online Sales , by Region USD Million (2025-2030)
  • Table 343. Jet Lag Therapy Drug Stores , by Region USD Million (2025-2030)
  • Table 344. Jet Lag Therapy: by Route Of Administration(USD Million)
  • Table 345. Jet Lag Therapy Oral , by Region USD Million (2025-2030)
  • Table 346. Jet Lag Therapy Injection , by Region USD Million (2025-2030)
  • Table 347. Jet Lag Therapy: by Drug Class(USD Million)
  • Table 348. Jet Lag Therapy Non-Benzodiazepines , by Region USD Million (2025-2030)
  • Table 349. Jet Lag Therapy Benzodiazepines , by Region USD Million (2025-2030)
  • Table 350. Jet Lag Therapy Over The Counter Drugs , by Region USD Million (2025-2030)
  • Table 351. Jet Lag Therapy Melatonin , by Region USD Million (2025-2030)
  • Table 352. Jet Lag Therapy Herbal and Natural Products , by Region USD Million (2025-2030)
  • Table 353. Jet Lag Therapy: by Devices(USD Million)
  • Table 354. Jet Lag Therapy Prescription Medication , by Region USD Million (2025-2030)
  • Table 355. Jet Lag Therapy Jet Lag Wearable Devices , by Region USD Million (2025-2030)
  • Table 356. Jet Lag Therapy LightBox , by Region USD Million (2025-2030)
  • Table 357. Jet Lag Therapy Melatonin , by Region USD Million (2025-2030)
  • Table 358. Jet Lag Therapy Herbal Medication , by Region USD Million (2025-2030)
  • Table 359. South America Jet Lag Therapy, by Country USD Million (2025-2030)
  • Table 360. South America Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 361. South America Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 362. South America Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 363. South America Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 364. South America Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 365. Brazil Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 366. Brazil Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 367. Brazil Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 368. Brazil Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 369. Brazil Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 370. Argentina Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 371. Argentina Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 372. Argentina Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 373. Argentina Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 374. Argentina Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 375. Rest of South America Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 376. Rest of South America Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 377. Rest of South America Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 378. Rest of South America Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 379. Rest of South America Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 380. Asia Pacific Jet Lag Therapy, by Country USD Million (2025-2030)
  • Table 381. Asia Pacific Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 382. Asia Pacific Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 383. Asia Pacific Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 384. Asia Pacific Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 385. Asia Pacific Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 386. China Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 387. China Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 388. China Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 389. China Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 390. China Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 391. Japan Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 392. Japan Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 393. Japan Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 394. Japan Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 395. Japan Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 396. India Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 397. India Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 398. India Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 399. India Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 400. India Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 401. South Korea Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 402. South Korea Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 403. South Korea Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 404. South Korea Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 405. South Korea Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 406. Taiwan Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 407. Taiwan Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 408. Taiwan Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 409. Taiwan Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 410. Taiwan Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 411. Australia Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 412. Australia Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 413. Australia Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 414. Australia Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 415. Australia Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 416. Rest of Asia-Pacific Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 417. Rest of Asia-Pacific Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 418. Rest of Asia-Pacific Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 419. Rest of Asia-Pacific Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 420. Rest of Asia-Pacific Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 421. Europe Jet Lag Therapy, by Country USD Million (2025-2030)
  • Table 422. Europe Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 423. Europe Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 424. Europe Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 425. Europe Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 426. Europe Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 427. Germany Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 428. Germany Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 429. Germany Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 430. Germany Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 431. Germany Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 432. France Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 433. France Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 434. France Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 435. France Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 436. France Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 437. Italy Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 438. Italy Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 439. Italy Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 440. Italy Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 441. Italy Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 442. United Kingdom Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 443. United Kingdom Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 444. United Kingdom Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 445. United Kingdom Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 446. United Kingdom Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 447. Netherlands Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 448. Netherlands Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 449. Netherlands Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 450. Netherlands Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 451. Netherlands Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 452. Rest of Europe Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 453. Rest of Europe Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 454. Rest of Europe Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 455. Rest of Europe Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 456. Rest of Europe Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 457. MEA Jet Lag Therapy, by Country USD Million (2025-2030)
  • Table 458. MEA Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 459. MEA Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 460. MEA Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 461. MEA Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 462. MEA Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 463. Middle East Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 464. Middle East Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 465. Middle East Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 466. Middle East Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 467. Middle East Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 468. Africa Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 469. Africa Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 470. Africa Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 471. Africa Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 472. Africa Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 473. North America Jet Lag Therapy, by Country USD Million (2025-2030)
  • Table 474. North America Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 475. North America Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 476. North America Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 477. North America Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 478. North America Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 479. United States Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 480. United States Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 481. United States Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 482. United States Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 483. United States Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 484. Canada Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 485. Canada Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 486. Canada Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 487. Canada Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 488. Canada Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 489. Mexico Jet Lag Therapy, by Application USD Million (2025-2030)
  • Table 490. Mexico Jet Lag Therapy, by End Users USD Million (2025-2030)
  • Table 491. Mexico Jet Lag Therapy, by Route Of Administration USD Million (2025-2030)
  • Table 492. Mexico Jet Lag Therapy, by Drug Class USD Million (2025-2030)
  • Table 493. Mexico Jet Lag Therapy, by Devices USD Million (2025-2030)
  • Table 494. Jet Lag Therapy Sales: by Application(K Units)
  • Table 495. Jet Lag Therapy Sales Business Travelers , by Region K Units (2025-2030)
  • Table 496. Jet Lag Therapy Sales Cabin Crew , by Region K Units (2025-2030)
  • Table 497. Jet Lag Therapy Sales Athletes , by Region K Units (2025-2030)
  • Table 498. Jet Lag Therapy Sales Seasonal Travelers , by Region K Units (2025-2030)
  • Table 499. Jet Lag Therapy Sales Others , by Region K Units (2025-2030)
  • Table 500. Jet Lag Therapy Sales: by End Users(K Units)
  • Table 501. Jet Lag Therapy Sales Hospital Pharmacies , by Region K Units (2025-2030)
  • Table 502. Jet Lag Therapy Sales Retail Pharmacies , by Region K Units (2025-2030)
  • Table 503. Jet Lag Therapy Sales Online Sales , by Region K Units (2025-2030)
  • Table 504. Jet Lag Therapy Sales Drug Stores , by Region K Units (2025-2030)
  • Table 505. Jet Lag Therapy Sales: by Route Of Administration(K Units)
  • Table 506. Jet Lag Therapy Sales Oral , by Region K Units (2025-2030)
  • Table 507. Jet Lag Therapy Sales Injection , by Region K Units (2025-2030)
  • Table 508. Jet Lag Therapy Sales: by Drug Class(K Units)
  • Table 509. Jet Lag Therapy Sales Non-Benzodiazepines , by Region K Units (2025-2030)
  • Table 510. Jet Lag Therapy Sales Benzodiazepines , by Region K Units (2025-2030)
  • Table 511. Jet Lag Therapy Sales Over The Counter Drugs , by Region K Units (2025-2030)
  • Table 512. Jet Lag Therapy Sales Melatonin , by Region K Units (2025-2030)
  • Table 513. Jet Lag Therapy Sales Herbal and Natural Products , by Region K Units (2025-2030)
  • Table 514. Jet Lag Therapy Sales: by Devices(K Units)
  • Table 515. Jet Lag Therapy Sales Prescription Medication , by Region K Units (2025-2030)
  • Table 516. Jet Lag Therapy Sales Jet Lag Wearable Devices , by Region K Units (2025-2030)
  • Table 517. Jet Lag Therapy Sales LightBox , by Region K Units (2025-2030)
  • Table 518. Jet Lag Therapy Sales Melatonin , by Region K Units (2025-2030)
  • Table 519. Jet Lag Therapy Sales Herbal Medication , by Region K Units (2025-2030)
  • Table 520. South America Jet Lag Therapy Sales, by Country K Units (2025-2030)
  • Table 521. South America Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 522. South America Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 523. South America Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 524. South America Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 525. South America Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 526. Brazil Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 527. Brazil Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 528. Brazil Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 529. Brazil Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 530. Brazil Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 531. Argentina Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 532. Argentina Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 533. Argentina Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 534. Argentina Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 535. Argentina Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 536. Rest of South America Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 537. Rest of South America Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 538. Rest of South America Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 539. Rest of South America Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 540. Rest of South America Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 541. Asia Pacific Jet Lag Therapy Sales, by Country K Units (2025-2030)
  • Table 542. Asia Pacific Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 543. Asia Pacific Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 544. Asia Pacific Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 545. Asia Pacific Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 546. Asia Pacific Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 547. China Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 548. China Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 549. China Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 550. China Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 551. China Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 552. Japan Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 553. Japan Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 554. Japan Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 555. Japan Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 556. Japan Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 557. India Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 558. India Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 559. India Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 560. India Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 561. India Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 562. South Korea Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 563. South Korea Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 564. South Korea Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 565. South Korea Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 566. South Korea Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 567. Taiwan Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 568. Taiwan Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 569. Taiwan Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 570. Taiwan Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 571. Taiwan Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 572. Australia Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 573. Australia Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 574. Australia Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 575. Australia Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 576. Australia Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 577. Rest of Asia-Pacific Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 578. Rest of Asia-Pacific Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 579. Rest of Asia-Pacific Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 580. Rest of Asia-Pacific Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 581. Rest of Asia-Pacific Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 582. Europe Jet Lag Therapy Sales, by Country K Units (2025-2030)
  • Table 583. Europe Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 584. Europe Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 585. Europe Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 586. Europe Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 587. Europe Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 588. Germany Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 589. Germany Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 590. Germany Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 591. Germany Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 592. Germany Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 593. France Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 594. France Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 595. France Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 596. France Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 597. France Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 598. Italy Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 599. Italy Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 600. Italy Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 601. Italy Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 602. Italy Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 603. United Kingdom Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 604. United Kingdom Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 605. United Kingdom Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 606. United Kingdom Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 607. United Kingdom Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 608. Netherlands Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 609. Netherlands Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 610. Netherlands Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 611. Netherlands Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 612. Netherlands Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 613. Rest of Europe Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 614. Rest of Europe Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 615. Rest of Europe Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 616. Rest of Europe Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 617. Rest of Europe Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 618. MEA Jet Lag Therapy Sales, by Country K Units (2025-2030)
  • Table 619. MEA Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 620. MEA Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 621. MEA Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 622. MEA Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 623. MEA Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 624. Middle East Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 625. Middle East Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 626. Middle East Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 627. Middle East Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 628. Middle East Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 629. Africa Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 630. Africa Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 631. Africa Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 632. Africa Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 633. Africa Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 634. North America Jet Lag Therapy Sales, by Country K Units (2025-2030)
  • Table 635. North America Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 636. North America Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 637. North America Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 638. North America Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 639. North America Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 640. United States Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 641. United States Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 642. United States Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 643. United States Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 644. United States Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 645. Canada Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 646. Canada Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 647. Canada Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 648. Canada Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 649. Canada Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 650. Mexico Jet Lag Therapy Sales, by Application K Units (2025-2030)
  • Table 651. Mexico Jet Lag Therapy Sales, by End Users K Units (2025-2030)
  • Table 652. Mexico Jet Lag Therapy Sales, by Route Of Administration K Units (2025-2030)
  • Table 653. Mexico Jet Lag Therapy Sales, by Drug Class K Units (2025-2030)
  • Table 654. Mexico Jet Lag Therapy Sales, by Devices K Units (2025-2030)
  • Table 655. Research Programs/Design for This Report
  • Table 656. Key Data Information from Secondary Sources
  • Table 657. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Jet Lag Therapy: by Application USD Million (2018-2023)
  • Figure 5. Global Jet Lag Therapy: by End Users USD Million (2018-2023)
  • Figure 6. Global Jet Lag Therapy: by Route Of Administration USD Million (2018-2023)
  • Figure 7. Global Jet Lag Therapy: by Drug Class USD Million (2018-2023)
  • Figure 8. Global Jet Lag Therapy: by Devices USD Million (2018-2023)
  • Figure 9. South America Jet Lag Therapy Share (%), by Country
  • Figure 10. Asia Pacific Jet Lag Therapy Share (%), by Country
  • Figure 11. Europe Jet Lag Therapy Share (%), by Country
  • Figure 12. MEA Jet Lag Therapy Share (%), by Country
  • Figure 13. North America Jet Lag Therapy Share (%), by Country
  • Figure 14. Global Jet Lag Therapy: by Application K Units (2018-2023)
  • Figure 15. Global Jet Lag Therapy: by End Users K Units (2018-2023)
  • Figure 16. Global Jet Lag Therapy: by Route Of Administration K Units (2018-2023)
  • Figure 17. Global Jet Lag Therapy: by Drug Class K Units (2018-2023)
  • Figure 18. Global Jet Lag Therapy: by Devices K Units (2018-2023)
  • Figure 19. South America Jet Lag Therapy Share (%), by Country
  • Figure 20. Asia Pacific Jet Lag Therapy Share (%), by Country
  • Figure 21. Europe Jet Lag Therapy Share (%), by Country
  • Figure 22. MEA Jet Lag Therapy Share (%), by Country
  • Figure 23. North America Jet Lag Therapy Share (%), by Country
  • Figure 24. Global Jet Lag Therapy share by Players 2023 (%)
  • Figure 25. Global Jet Lag Therapy share by Players (Top 3) 2023(%)
  • Figure 26. Global Jet Lag Therapy share by Players (Top 5) 2023(%)
  • Figure 27. BCG Matrix for key Companies
  • Figure 28. Ayo (Novalogy) (United States) Revenue, Net Income and Gross profit
  • Figure 29. Ayo (Novalogy) (United States) Revenue: by Geography 2023
  • Figure 30. The Litebook Company Ltd (Canada) Revenue, Net Income and Gross profit
  • Figure 31. The Litebook Company Ltd (Canada) Revenue: by Geography 2023
  • Figure 32. Lucimed (Belgium) Revenue, Net Income and Gross profit
  • Figure 33. Lucimed (Belgium) Revenue: by Geography 2023
  • Figure 34. Clinigen Group (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. Clinigen Group (United Kingdom) Revenue: by Geography 2023
  • Figure 36. Vanda Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 37. Vanda Pharmaceuticals (United States) Revenue: by Geography 2023
  • Figure 38. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 39. Pfizer (United States) Revenue: by Geography 2023
  • Figure 40. Jamieson Laboratories Ltd. (Canada) Revenue, Net Income and Gross profit
  • Figure 41. Jamieson Laboratories Ltd. (Canada) Revenue: by Geography 2023
  • Figure 42. Lumie (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 43. Lumie (United Kingdom) Revenue: by Geography 2023
  • Figure 44. Northern Light Technologies (Canada) Revenue, Net Income and Gross profit
  • Figure 45. Northern Light Technologies (Canada) Revenue: by Geography 2023
  • Figure 46. Propeaq (Netherlands) Revenue, Net Income and Gross profit
  • Figure 47. Propeaq (Netherlands) Revenue: by Geography 2023
  • Figure 48. Global Jet Lag Therapy: by Application USD Million (2025-2030)
  • Figure 49. Global Jet Lag Therapy: by End Users USD Million (2025-2030)
  • Figure 50. Global Jet Lag Therapy: by Route Of Administration USD Million (2025-2030)
  • Figure 51. Global Jet Lag Therapy: by Drug Class USD Million (2025-2030)
  • Figure 52. Global Jet Lag Therapy: by Devices USD Million (2025-2030)
  • Figure 53. South America Jet Lag Therapy Share (%), by Country
  • Figure 54. Asia Pacific Jet Lag Therapy Share (%), by Country
  • Figure 55. Europe Jet Lag Therapy Share (%), by Country
  • Figure 56. MEA Jet Lag Therapy Share (%), by Country
  • Figure 57. North America Jet Lag Therapy Share (%), by Country
  • Figure 58. Global Jet Lag Therapy: by Application K Units (2025-2030)
  • Figure 59. Global Jet Lag Therapy: by End Users K Units (2025-2030)
  • Figure 60. Global Jet Lag Therapy: by Route Of Administration K Units (2025-2030)
  • Figure 61. Global Jet Lag Therapy: by Drug Class K Units (2025-2030)
  • Figure 62. Global Jet Lag Therapy: by Devices K Units (2025-2030)
  • Figure 63. South America Jet Lag Therapy Share (%), by Country
  • Figure 64. Asia Pacific Jet Lag Therapy Share (%), by Country
  • Figure 65. Europe Jet Lag Therapy Share (%), by Country
  • Figure 66. MEA Jet Lag Therapy Share (%), by Country
  • Figure 67. North America Jet Lag Therapy Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Ayo (Novalogy) (United States)
  • The Litebook Company Ltd (Canada)
  • Lucimed (Belgium)
  • Clinigen Group (United Kingdom)
  • Vanda Pharmaceuticals (United States)
  • Pfizer (United States)
  • Jamieson Laboratories Ltd. (Canada)
  • Lumie (United Kingdom)
  • Northern Light Technologies (Canada)
  • Propeaq (Netherlands)
Additional players considered in the study are as follows:
Re-Timer (Australia) , HumanCharger (Finland) , Verilux, Inc. (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 232 Pages 62 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Jet Lag Therapy Quantitative research analysis
Global Jet Lag Therapy Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Ayo (Novalogy) (United States), The Litebook Company Ltd (Canada), Lucimed (Belgium), Clinigen Group (United Kingdom), Vanda Pharmaceuticals (United States), Pfizer (United States), Jamieson Laboratories Ltd. (Canada), Lumie (United Kingdom), Northern Light Technologies (Canada) and Propeaq (Netherlands) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technology Advancement in Components in Therapies " is seen as one of major influencing trends for Jet Lag Therapy Market during projected period 2023-2030.
The Jet Lag Therapy market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Jet Lag Therapy Report?

Have a Query? Click Here

Other Related Reports

Atrial Fibrillation Surgery Comprehensive Study by Type (Ablation Surgeries (Radiofrequency Ablation, Sonar, Microwave, Cryoablation), Atrioventricular Node Ablation, Maze Procedure), Application (Mi...
$ 3650
Electric Oral Care Comprehensive Study by Type (Water Flosser/Oral Irrigators, Air Flosser), Application (Online Stores, Retail Stores), End users (Adults, Children, Geriatric Population), Distributi...
$ 3350
Blood Screening Comprehensive Study by Type (Reagents & Kits, Instruments, Software & Services), Application (Blood Bank, Hospitals), Technology (Nucleic Acid Amplification Test (NAT), ELISA, Chemilu...
$ 3650
Tuberculosis Testing Comprehensive Study by Type (TB skin test (TST), TB blood tests, Others), Application (Hospitals, Clinics, Others), Disease (Active Tuberculosis, Latent Tuberculosis) Players and...
$ 3500
Human Papilloma Virus Testing Comprehensive Study by Type (Pap Smear Test, HPV DNA Test), Application (Diagnostic Centers, Hospitals, Clinic), Product Types (Consumables, Systems), Valence (Bivalent,...
$ 3650
IoT Healthcare Comprehensive Study by Application (Telemedicine, Work Flow Management, Connected Imaging, Medication Management), By Component (System and Software, Medical Devices, Services), By End...
$ 3650